prikaz prve stranice dokumenta Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
  Download
PDF 1.48 MB
Scientific paper - Original scientific paper
Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
Diagnostics, 14 (2024), 13; 1383. https://doi.org/10.3390/diagnostics14131383
Radić, Josipa; Vučković, Marijana; Đogaš, Hana; Gelemanović, Andrea; Belančić, Andrej; Radić, Mislav

Cite this document

Radić, J., Vučković, M., Đogaš, H., Gelemanović, A., Belančić, A. & Radić, M. (2024). Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?. Diagnostics, 14. (13). doi: 10.3390/diagnostics14131383

Radić, Josipa, et al. "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?." Diagnostics, vol. 14, no. 13, 2024. https://doi.org/10.3390/diagnostics14131383

Radić, Josipa, Marijana Vučković, Hana Đogaš, Andrea Gelemanović, Andrej Belančić and Mislav Radić. "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?." Diagnostics 14, no. 13 (2024). https://doi.org/10.3390/diagnostics14131383

Radić, J., et al. (2024) 'Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?', Diagnostics, 14(13). doi: 10.3390/diagnostics14131383

Radić J, Vučković M, Đogaš H, Gelemanović A, Belančić A, Radić M. Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?. Diagnostics [Internet]. 2024 June 28 [cited 2025 January 23];14(13). doi: 10.3390/diagnostics14131383

J. Radić, M. Vučković, H. Đogaš, A. Gelemanović, A. Belančić and M. Radić, "Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?", Diagnostics, vol. 14, no. 13, June 2024. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:575293. [Accessed: 23 January 2025]

Please login to the repository to save this object to your list.
Metadata
Title (english)Are There Differences in Skin Autofluorescence-Measured Advanced Glycation End-Product Levels between Chronic Kidney Disease and Kidney Transplant Recipients?
AuthorJosipa Radić
AuthorMarijana Vučković
AuthorHana Đogaš
AuthorAndrea Gelemanović
AuthorAndrej Belančić
AuthorMislav Radić
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Pharmacology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Clinical Pharmacology and Toxicology
Abstract (english)
The aim of this cross-sectional study was to evaluate the differences in the levels of advanced glycation end products (AGE) between patients with chronic kidney disease (CKD) and kidney transplant recipients (KTRs) and to investigate the risk factors for the AGE levels in each group of these patients. There were 217 participants total, of which 99 (45.6%) were KTRs and 118 (54.4%) had CKD. Data on the levels of AGE, body mass composition, anthropometric parameters, central and peripheral blood pressure, and clinical and laboratory parameters were gathered for each study participant. The AGE values of the CKD and KTRs groups did not differ from one another. In both groups, a lower estimated glomerular filtration rate, male sex, and older age were positive predictors for increased AGE values. Furthermore, higher levels of AGE were linked to lower central systolic blood pressure (cSBP) in the CKD group, whilst, in the KTRs group, higher levels of AGE were linked to a shorter time since kidney transplantation (KTx), more years of dialysis prior to KTx, lower levels of trunk visceral fat, the presence of arterial hypertension, and the absence of prescriptions for the antihypertensive medications urapidil and angiotensin II receptor blockers. Further studies are needed to better understand the above associations. Consequently, a personalised multidisciplinary approach to assess the cardiovascular as well as dietary and lifestyle risk factors to reduce the AGE levels in both KTRs and CKD patients may be implemented.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleDiagnostics
Numberingvol. 14, no. 13, 1383
e-ISSN2075-4418
DOIhttps://doi.org/10.3390/diagnostics14131383
URN:NBNurn:nbn:hr:184:575293
Publication2024-06-28
Document URLhttps://www.mdpi.com/2075-4418/14/13/1383
Type of resourceText
Access conditionsOpen access
Terms of useLicence Attribution 4.0 International (CC BY 4.0) icon
Created on2024-08-23 07:27:05